Articles for tag: Technology

January 8, 2024

Ron Finklestien

Wall Street Analysts’ Perspective on Super Micro’s Future Stock Performance Wall Street Analysts’ Perspective on Super Micro’s Future Stock Performance

Before diving into the reliability of brokerage recommendations, let’s take a look at what Wall Street analysts have to say about Super Micro Computer (SMCI). The Brokerage Verdict Super Micro currently boasts an average brokerage recommendation (ABR) of 1.57, indicating a consensus between Strong Buy and Buy, based on assessments from seven brokerage firms. Out of these seven recommendations, an overwhelming 71.4% vouch for a Strong Buy rating. Understanding Brokerage Recommendations While the ABR leans towards a favorable view of Super Micro, it is essential to exercise caution when solely relying on this metric for investment decisions. Numerous studies have

January 8, 2024

Ron Finklestien

Investors Eye AKYA, DRTS, and TRUP as Top Momentum Stocks

A trio of stocks is turning heads today with their impressive buy rank and robust momentum. The allure of starting off 2024 with these potential high-flyers is palpable, and investors are poised to dive into Akoya Biosciences, Alpha Tau Medical Ltd., and Trupanion, Inc. Let’s take a closer look at why these picks are creating such a buzz in the market. Akoya Biosciences, Inc.: Breaking Scientific Barriers Akoya Biosciences, Inc. AKYA has been making waves in the life sciences technology sector, earning a Zacks Rank #1. In the past 60 days, the Zacks Consensus Estimate for its current-year earnings has

January 8, 2024

Ron Finklestien

Sherwin-Williams Company’s Stocks on an Upward Trajectory! Sherwin-Williams Company’s Stocks on an Upward Trajectory!

The Sherwin-Williams Company’s SHW shares have rallied 17.8% in the past three months, modestly outperforming its industry’s growth of 16% over the same period. The company has topped the S&P 500’s roughly 8.8% rise over the same period. Image Source: Zacks Investment Research Let’s take a look at the factors that are driving this Zacks Rank #2 (Buy) stock. Sherwin-Williams is gaining from the strength in its Paint Stores Group division, along with initiatives to reduce costs and increase pricing, as well as expanded operations. The company is growing its retail operations in response to robust domestic demand. Auto refinishing

January 8, 2024

Ron Finklestien

Best Growth Stocks to Buy for January 8th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 8th: MercadoLibre, Inc. MELI: This e-commerce company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days. MercadoLibre, Inc. Price and Consensus MercadoLibre, Inc. price-consensus-chart | MercadoLibre, Inc. Quote MercadoLibre has a PEG ratio of 0.79 compared with 1.25 for the industry. The company possesses a Growth Score  of A. MercadoLibre, Inc. PEG Ratio (TTM) MercadoLibre, Inc. peg-ratio-ttm | MercadoLibre, Inc. Quote TIM S.A. TIMB: This telecommunications company carries

January 8, 2024

Ron Finklestien

The Most Compelling Stocks to Consider Investing in on January 8th

Discerning investors should earmark the following stocks, which exhibit a buy rank and robust value attributes, for potential investment on January 8th: QuantaSing Group Limited QSG stands as a China-based online learning services enterprise with a stellar Zacks Rank #1. The company has observed the Zacks Consensus Estimate for its current year earnings skyrocket by an impressive 325% over the past 60 days. The Lure of QuantaSing Group Limited Unsponsored ADR’s Price and Consensus QuantaSing Group Limited Unsponsored ADR price-consensus-chart | QuantaSing Group Limited Unsponsored ADR Quote QuantaSing boasts a favorable price-to-earnings ratio (P/E) of 5.02, in comparison to the

January 5, 2024

Ron Finklestien

Exploring Ally and Synchrony Financial Stocks for Potential Upsides Time to Buy Ally or Synchrony Financial Stock for Higher Highs?

As the financial sector gears up for the Q4 earnings season, multiple eyes are on big banks such as JP Morgan JPM and Bank of America BAC to set the tone. However, amidst these big players, consumer lending stocks like Ally Financial ALLY and Synchrony Financial SYF have been shining bright, standing out in the financial sector. Both these companies are hovering near their 52-week highs and are scheduled to report their Q4 results later this month on January 19 and 23, respectively. Before diving into their reports, let’s analyze whether it’s the right time to consider investing in Ally

January 5, 2024

Ron Finklestien

Assessing Snowflake Inc. (SNOW) as an Investment from Wall Street’s Rose-Colored Perspective

When thinking over potential stock actions, investors often turn to the advice of analysts. The media frequently trumpets changes in ratings by these sell-side analysts, but how impactful are these ratings really? Before delving into the reliability of brokerage recommendations and how to leverage them, let’s first delve into Wall Street’s stance on Snowflake Inc. (SNOW). Brokerage Recommendations for Snowflake Inc. Snowflake Inc. currently boasts an average brokerage recommendation (ABR) of 1.79, falling between Strong Buy and Buy on a scale of 1 to 5, with 38 brokerage firms contributing recommendations. Of these, 24 render Strong Buy and 2 declare

January 5, 2024

Ron Finklestien

Top Momentum Stocks for Smart Investing Top Momentum Stocks for Smart Investing

Every savvy investor knows the value of uncovering those hidden gems that can potentially yield significant returns. Today, on January 5th, we present three stocks with buy rank and robust momentum characteristics for discerning investors to consider. Organogenesis Holdings Inc. (ORGO) Organogenesis has seen its shares surge by 31.8% over the last three months, outpacing the S&P 500’s 8.6% advance. With a Zacks Rank #1 and a Momentum Score of A, the regenerative medicine company has witnessed a 500% increase in the Zacks Consensus Estimate for its current year earnings over the past 60 days. Cal-Maine Foods, Inc. (CALM) Cal-Maine

January 5, 2024

Ron Finklestien

Discover Five Thriving Stocks Worth Owning

Today marks the induction of five companies into the prestigious Zacks Rank #1 (Strong Buy) List. This elite group includes: Organogenesis Holdings Inc. (ORGO), a trailblazing regenerative medicine company, has witnessed a jaw-dropping 500% surge in the Zacks Consensus Estimate for its current year earnings over the last 60 days. The Promising Trajectory of Organogenesis Investigate Organogenesis’ price and consensus chart here | The Organogenesis Quote Cal-Maine Foods, Inc. (CALM), a prominent producer of shell eggs, has experienced a remarkable 77.4% surge in the Zacks Consensus Estimate for its current year earnings over the last 60 days. A Glimpse into

January 5, 2024

Ron Finklestien

Insightful Investments: Identifying Potential Stocks in Market Downturn Insightful Investments: Identifying Potential Stocks in Market Downturn

Today’s episode of Full Court Finance at Zacks dives into the much-needed market pullback to start 2024, and why investors might want to start taking advantage of the downturn. The episode then digs into two highly-ranked stocks—Encompass Health (EHC)and Shift4 Payments (FOUR)—with strong growth potential in key industries that investors might want to buy amid the early 2024 cooldown.   Market Rebound Amidst Pullback The Nasdaq posted its fifth-straight drop on Thursday, marking its longest losing streak since October 2022. That might scare off some investors, but it’s worth constantly remembering that stocks without fail pull back to key moving averages